Apremilast Impurity FA manufacturers
- Apremilast Impurity FA
-
- $0.00 / 10mg
-
2025-09-25
- CAS:2077897-94-8
- Min. Order: 10mg
- Purity: 98%
- Supply Ability: 500mg
|
| | Apremilast Impurity FA Basic information |
| Product Name: | Apremilast Impurity FA | | Synonyms: | Apremilast Impurity FA;Apremilast Impurity 39;Formamide, N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-;(S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)- 1,3-dioxoisoindolin-4-yl)formamide;Apste impurity 6;(S)-N-acetyl-N-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)acetamide | | CAS: | 2077897-94-8 | | MF: | C21H22N2O7S | | MW: | 446.47 | | EINECS: | | | Product Categories: | | | Mol File: | 2077897-94-8.mol |  |
| | Apremilast Impurity FA Chemical Properties |
| Boiling point | 738.1±60.0 °C(Predicted) | | density | 1.408±0.06 g/cm3(Predicted) | | solubility | Chloroform (Sparingly), Methanol (Slightly) | | pka | 13.88±0.20(Predicted) | | form | Solid | | color | White to Off-White |
| | Apremilast Impurity FA Usage And Synthesis |
| Uses | N-Desacetyl-N-formyl Apremilast is the impurity of Apremilast (A729700), which is an oral phosphodiesterase 4 inhibitor used in the treatment of psoriatic arthritis. |
| | Apremilast Impurity FA Preparation Products And Raw materials |
|